Calluna Pharma AS, a clinical stage biotechnology company pioneering first-in-class antibodies to treat inflammatory and fibrotic diseases, today announced that Gijs van den Brink, MD, PhD, has been ...
Ukraine claimed it carried out an underwater drone strike on Dec. 15, the first such attack in maritime warfare, that ...
Jalen Hurts and the Eagles silenced some criticism, ended a losing streak and are now on the brink of a repeat championship.
The upcoming ban is a result of the National Defense Authorization Act, which requires companies like DJI to pass a formal ...
Quantum eMotion is a cybersecurity firm applying quantum innovations to the cybersecurity market. Read why I view QNCCF stock ...
In Northwest Alaska, a proposed 211-mile mining road has divided an Inupiaq community already devastated by climate change.
Since January 2024, Burundi has been experiencing a slow-moving yet profound economic crisis, born from a cascade of political decisions that have transformed this landlocked Great Lakes nation into ...
Discover how Netskope, Inc. is leading SASE innovation with 34% ARR growth, AI-driven security, and global expansion. Click ...
Brink's on Thursday said the new buyback expires at the end of 2027 and is in addition to a $500 million program that expires at the end of this year and had $143 million remaining as of Sept. 30.
The new $750 million authorization was approved by the Brink’s Board of Directors on December 10, 2025, and will expire on December 31, 2027. The new authorization is in addition to the previous $500 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback